The two sector indices - SXI LIFE SCIENCES® and SXI Bio+Medtech® give the industry greater
visibility in the financial market and have a positive impact on liquidity. The maximum
weighting of any given stock is limited to 10%, which gives greater prominence to small- and
medium-sized companies.
The SXI LIFE SCIENCES® index comprises companies from the pharmaceutical, biotechnology and medical
technology areas, while its sub-index - the SXI Bio+Medtech® - focuses solely on bio- and medtech
companies. Both are open to Swiss and foreign companies alike and since their initial calculation in
December 1999 the two indices have also turned in impressive performances on an international comparison.
